New combo therapy aims to ease overactive bladder symptoms in women
NCT ID NCT07429734
First seen Feb 26, 2026 · Last updated Apr 30, 2026 · Updated 7 times
Summary
This study compares a combination of two drugs (solifenacin and gabapentin) against solifenacin alone for treating overactive bladder in women. The goal is to see if the combination better reduces symptoms like frequent urination and urgency. Sixty women with moderate to severe symptoms will be followed for 3 months to track improvements and side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERACTIVE BLADDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Urology and Nephrology center - Mansoura University
Al Mansurah, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.